Dianthus Therapeutics, Inc. (DNTH) vs Telix Pharmaceuticals Limited (TLX)
- Dianthus Therapeutics, Inc. DNTH 72.09 −3.27%
- Telix Pharmaceuticals Limited TLX 10.69 +1.14%
Dianthus Therapeutics, Inc. and Telix Pharmaceuticals Limited are both Biotechnology companies. Dianthus Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.6B — 1.2× the size. Across the 9 metrics below, Telix Pharmaceuticals Limited leads on 5 and Dianthus Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | DNTH | TLX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (11,441.39%) | — | 0.00% |
| Net margin | (10,096.95%) | — | 0.00% |
| Free cash flow margin | (8,177.99%) | 0.00% | 0.00% |
| Return on equity | (26.07%) | 0.00% | (56.36%) |
| Return on assets | (24.98%) | 0.00% | (48.04%) |
| Return on invested capital | (47.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack